Valion Bio
VBIO
10 hedge funds and large institutions have $69.8K invested in Valion Bio in 2024 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 1 increasing their positions, 5 reducing their positions, and 3 closing their positions.
0% more funds holding
Funds holding: 10 → 10 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
0.32% less ownership
Funds ownership: 0.59% → 0.27% (-0.32%)
71% less capital invested
Capital invested by funds: $241K → $69.8K (-$171K)
80% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 5
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$10.1K |
| 2 |
Renaissance Technologies
New York
|
+$6.25K |
| 3 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$5.6K |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
+$3.93K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CCC
Cable Car Capital
San Francisco,
California
|
-$109K |
| 2 |
WAM
Warberg Asset Management
Winnetka,
Illinois
|
-$31.2K |
| 3 |
VF
Virtu Financial
New York
|
-$7.48K |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$5.63K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$5.34K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
UBS Group
Zurich,
Switzerland
| $23.6K | -$5.34K | -885 | -14% |
|
2
Vanguard Group
Malvern,
Pennsylvania
| $12K | – | – | – |
|
3
Geode Capital Management
Boston,
Massachusetts
| $9.1K | -$175 | -29 | -1% |
|
|
TSS
4
Two Sigma Securities
New York
| $7.12K | +$10.1K | +1,678 | New |
|
|
VF
5
Virtu Financial
New York
| $5K | -$7.48K | -1,238 | -50% |
|
|
TRCT
6
Tower Research Capital (TRC)
New York
| $4.59K | +$3.93K | +651 | +152% |
|
|
7
Renaissance Technologies
New York
| $4.39K | +$6.25K | +1,035 | New |
|
|
8
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| $3.93K | +$5.6K | +927 | New |
|
9
Osaic Holdings
Scottsdale,
Arizona
| $35 | -$6 | -1 | -11% |
|
10
Bank of America
Charlotte,
North Carolina
| $13 | -$6 | -1 | -25% |
|
|
CCC
11
Cable Car Capital
San Francisco,
California
| – | -$109K | -16,471 | Closed |
|
|
WAM
12
Warberg Asset Management
Winnetka,
Illinois
| – | -$31.2K | -4,706 | Closed |
|
|
13
Citadel Advisors
Miami,
Florida
| – | -$5.63K | -856 | Closed |
|
VBIO Hedge Fund Activity: Q3 2024 in Review
10 of the 6,965 institutional investors tracked by Wall St. Rank reported a position in Valion Bio (VBIO) for Q3 2024, worth a combined $69.8K — down 71% from $241K a quarter earlier.
Fund positioning in VBIO was balanced in Q3 2024: 3 funds opened new positions, 3 closed out, 1 added to existing stakes and 5 trimmed.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $10.1K. The largest seller was Cable Car Capital, exiting entirely with an estimated $109K sold.
- 10 institutional investors held Valion Bio (VBIO) as of Q3 2024, unchanged from Q2 2024.
- Funds reported $69.8K of Valion Bio stock for Q3 2024, down 71% quarter-over-quarter.
- 3 funds opened new Valion Bio positions in Q3 2024 and 3 closed out, a net change of 0 holders.
- The largest Valion Bio buyer in Q3 2024 was Two Sigma Securities, an estimated $10.1K added.
- The largest Valion Bio seller in Q3 2024 was Cable Car Capital, an estimated $109K sold.
Based on aggregated 13F filings for Q3 2024.